搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Shigella boydii serotype 18 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP464559SYZ
CSB-EP464559SYZ
CSB-BP464559SYZ
CSB-MP464559SYZ
CSB-EP464559SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Ribonuclease P protein component (rnpA) CSB-YP464560SYZ
CSB-EP464560SYZ
CSB-BP464560SYZ
CSB-MP464560SYZ
CSB-EP464560SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Tyrosine recombinase XerC (xerC) CSB-YP464561SYZ
CSB-EP464561SYZ
CSB-BP464561SYZ
CSB-MP464561SYZ
CSB-EP464561SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP464562SYZ
CSB-EP464562SYZ
CSB-BP464562SYZ
CSB-MP464562SYZ
CSB-EP464562SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP464563SYZ
CSB-EP464563SYZ
CSB-BP464563SYZ
CSB-MP464563SYZ
CSB-EP464563SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 8-amino-7-oxononanoate synthase (bioF) CSB-YP464564SYZ
CSB-EP464564SYZ
CSB-BP464564SYZ
CSB-MP464564SYZ
CSB-EP464564SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Probable GTP-binding protein EngB (engB) CSB-YP464565SYZ
CSB-EP464565SYZ
CSB-BP464565SYZ
CSB-MP464565SYZ
CSB-EP464565SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Cation-efflux pump FieF (fieF), partial CSB-YP464566SYZ1
CSB-EP464566SYZ1
CSB-BP464566SYZ1
CSB-MP464566SYZ1
CSB-EP464566SYZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (menH) CSB-YP464567SYZ
CSB-EP464567SYZ
CSB-BP464567SYZ
CSB-MP464567SYZ
CSB-EP464567SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP464568SYZ
CSB-EP464568SYZ
CSB-BP464568SYZ
CSB-MP464568SYZ
CSB-EP464568SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Erythronate-4-phosphate dehydrogenase (pdxB) CSB-YP464569SYZ
CSB-EP464569SYZ
CSB-BP464569SYZ
CSB-MP464569SYZ
CSB-EP464569SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Glycerol kinase (glpK), partial CSB-YP464570SYZ
CSB-EP464570SYZ
CSB-BP464570SYZ
CSB-MP464570SYZ
CSB-EP464570SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 50S ribosomal protein L11 (rplK) CSB-YP464571SYZ
CSB-EP464571SYZ
CSB-BP464571SYZ
CSB-MP464571SYZ
CSB-EP464571SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 50S ribosomal protein L7/L12 (rplL) CSB-YP464572SYZ
CSB-EP464572SYZ
CSB-BP464572SYZ
CSB-MP464572SYZ
CSB-EP464572SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Sulfoxide reductase heme-binding subunit YedZ (yedZ), partial CSB-YP464573SYZ1
CSB-EP464573SYZ1
CSB-BP464573SYZ1
CSB-MP464573SYZ1
CSB-EP464573SYZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP464574SYZ
CSB-EP464574SYZ
CSB-BP464574SYZ
CSB-MP464574SYZ
CSB-EP464574SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 LexA repressor (lexA) CSB-YP464575SYZ
CSB-EP464575SYZ
CSB-BP464575SYZ
CSB-MP464575SYZ
CSB-EP464575SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Cation/acetate symporter ActP (actP), partial CSB-YP464576SYZ
CSB-EP464576SYZ
CSB-BP464576SYZ
CSB-MP464576SYZ
CSB-EP464576SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 DnaA-homolog protein hda (hda) CSB-YP464577SYZ
CSB-EP464577SYZ
CSB-BP464577SYZ
CSB-MP464577SYZ
CSB-EP464577SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella boydii serotype 18 Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP464578SYZ
CSB-EP464578SYZ
CSB-BP464578SYZ
CSB-MP464578SYZ
CSB-EP464578SYZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>